Toldot Genetics

Whole Genome Sequencing Tools

Health Tech & Life Sciences
Acquired (Inactive) by Geneyx Genomex on Oct 2020 - closed due to acquisition

Company Overview

Snapshot

Founded in April 2012 by Dvir Dahary and Ami Haviv, Toldot Genetics operates with 1–10 employees. The company was acquired by Geneyx Genomex in October 2020, marking a significant exit in the Health Tech & Life Sciences sector.

Business overview

Toldot Genetics specializes in developing and applying algorithm-based tools for whole genome sequencing, aimed at assigning genetic variations to clinical conditions. The company provides geneticists and physicians with comprehensive analysis packages for exome sequencing data, facilitating the identification of causal mutations in rare genetic disorders. Additionally, Toldot Genetics offers tailored services to pharmaceutical and biotechnology companies, supporting their clinical pipelines from design to deep analysis of sequencing data. The company operates within the Health Tech & Life Sciences sector, with a focus on bioinformatics, genomics, and digital healthcare, serving doctors, academia, and pharmaceutical companies.

Strategic signal

In October 2020, Toldot Genetics was acquired by Geneyx Genomex. This acquisition highlights the increasing consolidation and strategic interest in companies providing advanced NGS sequencing analysis solutions within the genomics and precision medicine landscape, signaling a validation of Toldot Genetics' technology and market position.

Company Intelligence Q&A

What was a significant corporate milestone for Toldot Genetics?
Toldot Genetics was acquired by Geneyx Genomex in October 2020, leading to its current inactive status.
Who founded Toldot Genetics?
Toldot Genetics was co-founded by Dvir Dahary and Ami Haviv.
What is the primary focus of Toldot Genetics' technology?
Toldot Genetics focuses on developing and applying algorithm-based tools for whole genome sequencing to assign genetic variations to clinical conditions, particularly for identifying causal mutations of rare genetic disorders.
When did LifeMap Sciences partner with Toldot Genetics?
In February 2015, LifeMap Sciences partnered with Toldot Genetics to support the commercialization of next-generation sequencing variant analysis.
What product was launched in January 2016 related to Toldot Genetics' technology?
In January 2016, LifeMap Sciences, a subsidiary of BioTime, announced the launch of TGexTM, a knowledge-driven NGS analysis platform powered by the GeneCards Suite, which incorporated technology from Toldot Genetics.

External links